(BCLI) Brainstorm Cell - Performance -85.6% in 12m
Compare BCLI with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-92.10%
#184 in Group
Rel. Strength
3.61%
#7670 in Universe
Total Return 12m
-85.64%
#160 in Group
Total Return 5y
-98.66%
#179 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: BCLI (-85.6%) vs XBI (-14.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: BCLI vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BCLI
| Total Return (including Dividends) | BCLI | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 54.77% | 2.77% | 5.69% |
| 3 Months | -32.18% | -14.21% | -6.49% |
| 12 Months | -85.64% | -14.88% | 9.72% |
| 5 Years | -98.66% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | BCLI | XBI | S&P 500 |
| 1 Month | 86.7% | 57% | 89.4% |
| 3 Months | -85.3% | -82.3% | -72% |
| 12 Months | -91.0% | -53.1% | 49.3% |
| 5 Years | -94.8% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #101 | 50.6% | 46.4% |
| 3 Month | #148 | -21.0% | -27.5% |
| 12 Month | #161 | -83.1% | -86.9% |
| 5 Years | #179 | -98.2% | -99.4% |
FAQs
Does BCLI Brainstorm Cell outperforms the market?
No,
over the last 12 months BCLI made -85.64%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months BCLI made -32.18%, while XBI made -14.21%.
Over the last 3 months BCLI made -32.18%, while XBI made -14.21%.
Performance Comparison BCLI vs Indeces and Sectors
BCLI vs. Indices BCLI is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -7.24% | 49.1% | 1.87% | -95.4% |
| US NASDAQ 100 | QQQ | -7.51% | 47.4% | 1.46% | -96.4% |
| US Dow Jones Industrial 30 | DIA | -7.13% | 52.1% | 2.90% | -91.9% |
| German DAX 40 | DAX | -7.69% | 39.7% | -23.7% | -110% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.47% | 51.9% | 2.64% | -92.0% |
| Hongkong Hang Seng | HSI | -10.1% | 39.9% | -7.62% | -93.9% |
| India NIFTY 50 | INDA | -3.54% | 51.6% | -0.03% | -87.7% |
| Brasil Bovespa | EWZ | -10.3% | 43.2% | -7.34% | -79.4% |
BCLI vs. Sectors BCLI is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6.61% | 48.3% | -4.31% | -106% |
| Consumer Discretionary | XLY | -8.66% | 48.1% | 4.06% | -100% |
| Consumer Staples | XLP | -6.38% | 54.1% | -5.04% | -92.9% |
| Energy | XLE | -9.49% | 50.3% | 7.87% | -76.6% |
| Financial | XLF | -7.94% | 47.9% | -4.01% | -107% |
| Health Care | XLV | -3.14% | 57.8% | 7.10% | -79.6% |
| Industrial | XLI | -8.17% | 46.5% | 0.89% | -96.0% |
| Materials | XLB | -7.40% | 49.7% | 5.92% | -79.6% |
| Real Estate | XLRE | -6.45% | 47.9% | -0.51% | -99.2% |
| Technology | XLK | -8.08% | 45.1% | 4.14% | -91.7% |
| Utilities | XLU | -7.96% | 49.6% | -5.90% | -102% |
| Aerospace & Defense | XAR | -7.42% | 45.6% | -7.43% | -112% |
| Biotech | XBI | 0.48% | 52.0% | 22.9% | -70.8% |
| Homebuilder | XHB | -6.88% | 49.2% | 15.5% | -76.8% |
| Retail | XRT | -7.30% | 48.6% | 8.16% | -79.4% |